title: Olanzapine-induced neuroleptic malignant syndrome.
authors.forename: P R
authors.initials: PR
authors.lastname: Burkhard
authors.forename: F J
authors.initials: FJ
authors.lastname: Vingerhoets
authors.forename: C
authors.initials: C
authors.lastname: Alberque
authors.forename: T
authors.initials: T
authors.lastname: Landis
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012563:Schizophrenia, Paranoid / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine